Although fenofibrate can also reduce blood lipids and improve fatty liver, it is less effective than Fat-1 in improving HDL-C levels and NEFA levels, as well as optimizing plasma apolipoprotein levels and lipoprotein distribution. The gene discussed is FAT1; the disease is fatty liver disease.